Deletions within chromosome 6 (6q25 to 6qter) are the most consistent structural change observed in salivary gland carcinomas. To better de®ne the location of these deletions we investigated loss of heterozygosity (LOH) for 23 polymorphic markers within 19 salivary gland carcinomas covering several histological subtypes. LOH was observed in 47% of tumors, con®rming previous reports that such losses are frequent and occur in almost all histological subtypes of tumors. The highest frequency of LOH was found at, or distal to, D6S437. Seven tumors had allelic losses for D6S297 and/or D6S37. A second peak of loss was also observed at D6S262 and D6S32. In some tumors we observed LOH in one or the other of these two regions. In other tumors we observed loss of both regions with retention of intervening loci. These data suggest that two small deletions commonly occur, one between D6S262 and D6S32 (estimated to cover less than 1.5 Mb) and another between D6S297 and D6S446 (estimated to cover *2 Mb). These results extend previous studies by sublocalizing the regions of LOH and suggest that inactivation of one or more tumor suppressor genes located in these regions may be an important step in salivary gland carcinogenesis.
Introduction
Cytogenetic and molecular studies have shown that non-random deletions and loss of heterozygosity (LOH) within chromosome 6q are frequent events in many human neoplasms including breast carcinomas (Devilee et al., 1991a) , melanomas (Taguchi et al., 1993) , head and neck tumors (BockmuÈ hl et al., 1996) and renal carcinomas (Morita et al., 1991) , among others (Gaidano et al., 1992; Saito et al., 1992; Menasce et al., 1994; Queimado et al., 1995; Cooney et al., 1996; Tahara et al., 1996) . Chromosome transfer experiments indicate that chromosome 6 can suppress the tumorigenic (Trent et al., 1990) or metastatic activity (Welch et al., 1994) of melanoma cell lines and can induce senescence when introduced into immortalized cell lines (Hubbard-Smith et al., 1992) . Taken together, these results support the hypothesis that one or more generally important tumor suppressor genes reside within chromosome 6q.
Salivary gland carcinomas are a relatively rare tumor type. However, deletions of chromosome 6q are frequently observed in these tumors and are often the only cytogenetically visible alteration (Sandros et al., 1990; Jin et al., 1994) . Furthermore, these deletions appear to be the only structural abnormality shared in common between all of the histological subtypes of salivary gland carcinoma, with the exception of carcinoma ex-pleomorphic adenoma (Jin et al., 1994) , again suggesting that genes within this region play a critical part in the development of these malignant tumors. Previous cytogenetic studies have broadly mapped the 6q deletions into the 6q16-6qter region with an apparent clustering in the 6q25-6qter interval (Sandros et al., 1990; Jin et al., 1994) . In this report we have more precisely re®ned the location of these deletions by investigating loss of heterozygosity within chromosome 6q for 21 polymorphic DNA loci in a series of 19 salivary gland carcinomas. Our results indicate that two separate deleted regions occur. The minimal regions of overlap for each of these deletions suggest that they span relatively small genomic intervals that may now be tractable by physical mapping and positional cloning methods.
Results
In this study we investigated the presence of allelic imbalance within chromosome 6q in paired constitutional and tumor DNA samples from 19 patients with salivary gland carcinomas. Twenty-three polymorphic markers were used, 21 of which map within the long arm of chromosome 6, and these are listed in Table 1 . All samples were heterozygous for at least one locus within 6q, although the incidence of heterozygosity varied among dierent loci (ranging from 36% in the case of MYB to 100% for D6S446). The majority of the polymorphic markers used in this study were microsatellites, therefore evidence for allelic imbalance was in most cases derived from PCR analysis of tumor and constitutional DNA. Examples of allelic balance and imbalance for four representative cases are shown in Figure 1 . Thus, by PCR analysis, locus D6S262 is in allelic balance in case 11, but is in allelic imbalance in case 4. Southern blot analysis using probes speci®c to loci D6S32 and D6S37 are also shown in Figure 1 . For D6S37, this analysis indicates that cases 2 and 16 both exhibit allelic imbalance. For D6S32, case 4 is in allelic balance and case 11 exhibits allelic imbalance. Control hybridizations to the same Southern blots (data not shown) indicated that the observed imbalances were due to true allelic loss rather than allele ampli®cation.
We therefore conclude that the observed allelic imbalance is due to true loss of heterozygosity for one or more loci on chromosome 6q.
Taken together, the data from Southern blot and PCR analysis showed that allelic imbalance at 6q was present in nine of the 19 tumors (47%) and occurred at 12 of the 21 6q loci studied (Table 1 and Figure 2 ). In contrast, no allelic imbalance was found for the 6p 
CASE 11 CASE 4 CASE 16 CASE 2 Figure 1 Representative autoradiograms of 6q allelic imbalance in cases 2, 4, 11 and 16. Patient 11 shows retention of heterozygosity at locus D6S262 but absence of the upper allele at D6S32 (arrowhead). Patient 4 shows allelic imbalance at locus D6S262 (arrowhead) and retention of heterozygosity at locus D6S32. Patients 2 and 16 have absence of one allele at locus D6S37 (arrowhead) but show no allelic imbalance at loci D6S446 and D6S297, respectively. T, tumor DNA; N, constitutional DNA
Deletions at 6q in salivary gland carcinomas L Queimado et al control locus D6S29. The histological subtypes of tumors that were used in this study are shown in Table  2 . This list indicates that the nine tumors showing allelic imbalance covered the entire spectrum of studied salivary gland carcinoma subtypes, with the exception of myoepithelial carcinoma and low grade adenocarcinoma. Figure 2 summarizes the LOH results for the nine tumors that showed allelic imbalance, relative to the marker order on chromosome 6q. This deletion map indicates that the lowest frequency of LOH occurs in the centromere proximal region of chromosome 6q (proximal to D6S407). Another interval that appears to be retained relatively intact is the region surrounding MYB and D6S311. In four tumors (cases 4, 11, 12, 19) a peak of allelic loss is present at loci D6S262/D6S32. This appears to be an interstitial deletion in all of the four tumors since proximal and distal markers surrounding the lost markers are retained. In fact, in one of the tumors (case 11) this peak of LOH is the only observed loss within chromosome 6q. The smallest region of overlap includes D6S262 and D6S32. Thē anking markers for this deletion, which do not themselves show LOH, are D6S407 and D6S472. However, the actual minimal deleted interval appears to be¯anked by D6S262 and D6S32 since either one or the other, but not both, are deleted in these tumors (see the discussion for size estimates of this region). The most commonly deleted region in this panel of nine tumors occurs closer to the 6q telomere and peaks at D6S297/D6S37. Seven out of the nine tumors (cases 2, 4, 5, 6, 12, 16 and 17) show LOH in this interval (Figure 2) . Two of these cases (cases 4 and 12) also show LOH at the more proximal location (D6S262/ D6S32) with apparent retention of markers in between these two deleted regions. It is therefore unlikely that the entire end of 6q is lost in these cases. However, it is possible that two separate deleted chromosomes 6 are present in these tumors. Of the seven tumors that show LOH at D6S297/D6S37, three (cases 2, 16, 17) have what appear to be relatively small interstitial deletions that encompass D6S297 and/or D6S37. The¯anking markers for this peak of LOH are D6S297 and D6S447. Thus, in one case (cases 16), D6S297 does not shown LOH (see Figures 1 and 2 ) and in three cases (cases 2, 4, 17), D6S446 does not shown LOH (see Figures 1 and 2) .
Discussion
Previous cytogenetic studies have observed frequent deletions within the 6q25-qter region in salivary gland carcinomas (Sandros et al., 1990; Jin et al., 1994) . However, the one previous study of LOH on chromosome 6 in salivary gland carcinomas (Johns et al., 1996) failed to con®rm this high frequency at the molecular level. LOH was found in only two out of 15 Deletions at 6q in salivary gland carcinomas L Queimado et al malignant tumors (13%), and these deletions were restricted to adenoid cystic carcinomas. The results reported here, by contrast, agree well with the cytogenetic data and indicate that LOH in 6q is a frequent event in these types of tumors. The apparent discrepancy between the two reports is probably due to the fact that the previous study employed only two polymorphic markers within 6q, and both of these markers were located proximal to 6q25.2; i.e. within the region where we observe the lowest incidence of LOH (0 ± 27%). In the work described here we used a substantial panel of polymorphic markers spanning the long arm of chromosome 6 and this allowed us to detect LOH at 6q in practically all histological subtypes of salivary gland tumors. In addition to con®rming previous cytogenetic observations, there are two other important conclusions from this study. The ®rst is that two distinct areas of LOH exist within 6q in the tumor types that we have studied. The ®rst of these lies within 6q23 (D6S262/D6S32) and appears to be embedded within a more stable chromosomal region, as assessed by the retention of surrounding proximal and distal loci. Large cytogenetically visible interstitial deletions within this region have been occasionally described in salivary gland carcinomas (Sandros et al., 1990; Nordkvist et al., 1994) and interstitial loss of genetic material within 6q21-23 seems to be a relatively common event in the development of other types of benign tumors (Tahara et al., 1996) , malignant tumors (Gaidano et al., 1992; Queimado et al., 1995; Orphanos et al., 1995; Sheng et al., 1996) and in the immortalization of cell lines (Gualandi et al., 1994) . Interestingly, the loss of D6S32 has been previously reported in all immortalized clones of monochromosomal hybrids (Gualandi et al., 1994) and in all cases of a series of 51 gastric carcinomas that were informative for this locus and also exhibited LOH at any other 6q locus (Queimado et al., 1995) . Taken together, the data support the hypothesis that this small interstitial region of deletion at 6q is another good candidate for the localization of a tumor suppressor gene.
The second, and more frequent region of LOH, resides within 6q27 (D6S297/D6S37). Again, this region has been reported to be a recurrent target for LOH in a wide variety of other benign and malignant tumor types (Noviello et al., 1996; Gaidano et al., 1992; Saito et al., 1996; Queimado et al., 1995; Tahara et al., 1996; Cooke et al., 1996a; Chenevix-Trench et al., 1997) . Moreover, a candidate gene (SEN6) that might have a role in tumor suppression has been mapped into this general location (Banga et al., 1997) . This gene appears to mediate the immortalization of human cells after infection with SV40. However, the exact sublocalization of SEN6 within this region, and its role, if any, in tumor suppression remain to be investigated. Five additional candidate tumor and/or metastasis suppressor genes have been mapped to the long arm of chromosome 6: ER at 6q25.1 (Garcia et al., 1992) ; MnSOD at 6q25.2 (Church et al., 1993; Saord et al., 1994) ; IGFIIR at 6q25.3 (Hankins et al., 1996) ; SEN 6A at 6q14-21 (Sandhu et al., 1996) and LOT1 at 6q25 (Abdollahi et al., 1997) . None of these genes appears to map within the smallest regions of overlap de®ned in this study. However, it should be noted that correlations between the cytogenetic and genetic/physical maps are imprecise. All of these candidates will therefore have to be tested for placement within the physical maps of the regions we have de®ned.
Correlations between the genetic and physical maps can, however, be quite precisely drawn. When the smallest regions of overlaps that we have de®ned in this study are correlated with the available physical maps some estimates of true genomic distances can be drawn. The latest radiation hybrid maps of the entire human genome (Stewart et al., 1997) do not incorporate all of the markers that we used in this study. Nevertheless, even when more remote¯anking markers are used as landmarks the two regions we have de®ned (D6S262/D6S472 and D6S297/D6S446) appear to encompass only 1 ± 2 Mb in each case. A more useful estimate can be obtained by searching the Whitehead Institute Center for Genome Research Yeast Arti®cial Chromosome (YAC) map of chromosome 6. In the case of D6S297/D6S446 these two markers map to adjacent YACs (911c10 for D6S297 and 933f7 for D6S446) with a gap of unknown length in between. It is unlikely that this re¯ects a region of 45 Mb and is certainly not inconsistent with an estimate of *2 Mb for this region. In the case of D6S262/D6S472 the YAC map provides a much more re®ned estimate. Both of these loci map to the same two YACS (831d8 and 816b5) that are each approximately 1.5 Mb in length. This strongly suggests that this region of LOH is less than 1.5 Mb in size and renders it tractable by positional cloning technologies.
Recently, a link has been observed between the most active common fragile site in the human genome, 3p14.2 and cancer (Ohta et al., 1996) . In this regard, it is interesting to note that there are at least 4 fragile sites reported within 6q (Simonic and Gericke, 1996) . However, none of them appear to lie within the same chromosome bands that de®ne our regions of minimal deletion.
In conclusion, our results show that loss of genetic material at 6q is a frequent event in salivary gland carcinomas and occurs in all histological subtypes including carcinoma ex-pleomorphic adenoma. The data further extend previous cytogenetic observations by de®ning two small deleted regions at 6q21-23.3 and at 6q27 and support the hypothesis that one or more tumor suppressor genes are located in these relatively short regions of 6q, which are relevant to the development of malignant salivary gland tumors.
Materials and methods

Tumor specimens
Nineteen primary salivary gland carcinomas and corresponding normal tissue samples were collected from fresh tissue following surgical resection at IPOFG in Lisbon. None of the patients had received preoperative chemotherapy or radiotherapy. Tumors were classi®ed according to Seifert et al. (1990) . Clinical and histopathological data were available for all cases. Tissue samples were frozen immediately postoperatively in liquid nitrogen and stored at 7708C until DNA extraction. The percentage of non malignant cells in the tumor samples was estimated by scoring adjacent histological cryostat sections at low magni®cation. Microdissection of the specimen was performed on a cryostat, in the presence of an experienced pathologist (IF). Samples with less than 50% tumor cells were excluded from this study.
DNA extraction and DNA markers
High molecular weight DNA was extracted from 19 primary salivary gland carcinomas and respective samples of normal tissues (normal salivary gland and/or blood samples), according to standard procedures (MuÈ llenbach et al., 1989) . Twenty-three polymorphic markers (one to the short arm, one centromeric and 21 to the long arm of chromosome 6) were used in this study. They are listed, along with their approximate chromosomal locations in Table 1 . The relative localization of all microsatellite markers are in accord with the Whitehead Institute map (Hudson et al., 1995) . The relative localization of the other markers was based on Cooke et al. (1996b) (D6S29, D6Z1, MYB, D6S37) and on Buetow et al. (1994) (D6S32) . These loci included three restriction fragment length polymorphism (RFLP), 1 variable number of tandem repeats (VNTR) and 19 microsatellite markers. All the primers used for the ampli®cation of microsatellite markers were purchased from Research Genetics (Huntsville, AL). Markers pHHH157, p3B10 and pJCZ30 were obtained from American Type Culture Collection (Rockville, MD). Marker p308 was kindly provided by Dr EW Jabs (John Hopkins University).
LOH analysis
Methods for the analysis of RFLP/VNTR markers (restriction endonuclease digestions, gel electrophoresis, transfer to nylon membranes, probe labeling and hybridization) have been previously described (Queimado et al., 1995) . For microsatellite marker analysis, the polymerase chain reaction (PCR) was carried out in 96-well plates in a Perkin-Elmer (Norwalk, CT) 9600 GeneAmp PCR System. PCR reactions were performed in a total volume of 20 ml containing 30 ± 100 ng of DNA, 0.5 mM of each primer, 100 mM of each deoxynucleotide triphosphate except dCTP, 10 mM dCTP, 1 mCi of [a 32 P]dCTP and 0.5 units of Taq DNA polymerase. DNAs were ampli®ed for 30 cycles. Each cycle consisted of 948C for 1 min, annealing for 1 min, 728C for 1 min, with an initial denaturation step at 948C for 5 min and a ®nal extension step at 728C for 10 min. Annealing temperatures (55 ± 608C) varied according to the primer pairs used. PCR products were diluted 1 : 1 with loading buer (98% formamide, 0.1% xylene cyanol , 0.1% bromophenol blue, and 10 mM EDTA, pH 8.0) and denatured for 5 min at 948C. Subsequently, 2 ml of this solution was electrophoresed in a 6% polyacrylamide gel containing 6.9 M urea and 32.5% formamide, for 3 ± 4 h, at 50 W. After electrophoresis, gels were ®xed in 10% acetic acid, washed, dried and exposed to X-ray ®lm for 12 ± 24 h. Allele scorings were conducted independently by three investigators. Allelic imbalances were con®rmed by a second PCR and a second electrophoresis run.
Classi®cation of allelic imbalance
The relative intensity of the polymorphic fragments obtained by Southern blot analysis (RFLP/VNTR markers) or PCR (microsatellites markers) was estimated by visual inspection. Densitometric analysis of the intensity of the hybridization signals in cases where changes were visually detected was accomplished by scanning of radiographs and analysis with Ambis core software (Ambis Corporation). The imbalance factor was de®ned as the ratio of the allele intensities in the tumor sample relative to the ratio of the alleles in the constitutional DNA. A factor of 1.3 or lower was considered inconclusive (Devilee et al., 1991b) . LOH was de®ned as total loss of one allele or partial loss (reduction in the intensity of one allele) compared to the retained one. The latter was interpreted as contamination from normal tissue, if consistent with the evaluation of the respective cryostat sections before DNA extraction, or as clonal variation.
